SMR3B Activators
SMR3B activators pertain to a class of chemical agents that interact specifically with the human salivary protein SMR3B, which is a member of the SMR3 family of proteins. The gene encoding this protein is located on chromosome 4q13.3 and is closely related to another member of the same family, SMR3A. These proteins are secreted in bodily fluids, particularly in saliva, and are believed to play a role in several biological processes due to their location and expression patterns. SMR3B activators are chemical substances that bind to and increase the activity of SMR3B protein. They have been identified through various high-throughput screening methods that detect enhancements in the protein's natural function, which involves complex biochemical pathways. The activators may bind to the protein's active site or allosteric sites-regions of the protein other than the active site that can modulate the protein's function when bound by a molecule.
The molecular mechanisms through which SMR3B activators exert their influence involve a range of interactions at the cellular level. These activators may induce conformational changes in the SMR3B protein, which can result in an alteration of the protein's stability, its interaction with other salivary proteins, or its binding affinity with naturally occurring ligands. The precise chemical structure of SMR3B activators varies widely, as the specific chemical features necessary for activation can differ substantially. These may include various functional groups that are key for the interaction with the protein, such as hydrogen bond donors or acceptors, hydrophobic regions, and charged moieties. The structure-activity relationship (SAR) of these compounds is an area of interest, with many studies focusing on understanding how different chemical modifications can affect the interaction with SMR3B and consequently its activity. The activators might also influence the post-translational modifications of the SMR3B protein, which can have significant effects on its function. Understanding the biochemistry of SMR3B and how it is affected by these activators is crucial for elucidating the role of this protein in the complex network of molecular interactions in the human body.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a labdane diterpenoid that indirectly increases the activity of SMR3B by elevating intracellular cAMP levels. This increase in cAMP activates protein kinase A (PKA), which can phosphorylate proteins involved in the signaling pathways that SMR3B is part of, thereby enhancing its function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC plays a role in various signaling pathways, including those that involve SMR3B. Activation of PKC can lead to the phosphorylation of substrates that interact with SMR3B, thereby potentially enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can influence calcium-dependent signaling pathways. This elevation in calcium may indirectly activate SMR3B by affecting the pathways that are modulated by calcium signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, similar to forskolin. By activating beta-adrenergic receptors, isoproterenol can enhance the activity of SMR3B through the cAMP/PKA signaling pathway. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. By bypassing the receptor-mediated activation of adenylyl cyclase, it directly increases the activity of PKA, which can then enhance the activity of SMR3B through phosphorylation of related signaling proteins. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through its action on H2 receptors, increases intracellular cAMP levels, thereby activating PKA. The activation of PKA can lead to an enhancement of SMR3B activity by modulating proteins in the relevant signaling pathways. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is a Na+/K+-ATPase inhibitor, which can lead to changes in intracellular ion concentrations and secondary messenger systems, possibly affecting the signaling pathways that regulate SMR3B activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, similar to ionomycin. The elevation in intracellular calcium can indirectly enhance SMR3B activity through modulation of calcium-dependent signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to an increase in cAMP and cGMP levels. This can enhance SMR3B activity by indirectly increasing PKA and PKG activity, affecting the signaling pathways that SMR3B is involved in. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinase pathways (SAPKs), including JNK. By activating these pathways, anisomycin can influence the activity of SMR3B through phosphorylation of proteins involved in its signaling network. | ||||||